Stacy L. Taylor, SVP and General Counsel at Adaptive Biotechnologies Corp (ADPT), sold 495 shares at $40.00 ($20K) on 2021-09-07, disclosed to the SEC on 2021-09-09.
Scheduled sale ($20k) by SVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2023-03-08 | $277K | — | Filing → |
| ADPT | SELL | 2022-03-10 | $27K | — | Filing → |
| ADPT | SELL | 2022-03-08 | $19K | — | Filing → |